Genotyping of human cytochrome P450 2A6 (CYP2A6), a nicotine C‐oxidase
Open Access
- 6 November 1998
- journal article
- Published by Wiley in FEBS Letters
- Vol. 438 (3), 201-205
- https://doi.org/10.1016/s0014-5793(98)01297-6
Abstract
Cytochrome P450 2A6 (CYP2A6) is a polymorphic enzyme responsible for the oxidation of certain precarcinogens and drugs and is the major nicotine C‐oxidase. The role of CYP2A6 for nicotine elimination...Keywords
This publication has 30 references indexed in Scilit:
- CYP2A6 gene polymorphism and risk of liver cancer and cirrhosisPharmacogenetics, 1997
- Human Kidney Methoxyflurane and Sevoflurane MetabolismAnesthesiology, 1995
- Tips and tricks for long and accurate PCRTrends in Biochemical Sciences, 1994
- Role of Human Cytochromes P450 in the Metabolic Activation of Chemical Carcinogens and ToxinsDrug Metabolism Reviews, 1994
- Twenty-Year Trends in Coronary Risk Factors in North Karelia and in Other Areas of FinlandInternational Journal of Epidemiology, 1994
- Genetically variable metabolism of antidepressants and neuroleptic drugs in manPharmacogenetics, 1993
- High variability of nitrosamine metabolism among individuals: Role of cytochromes P450 2A6 and 2E1 in the dealkylation of N‐nitrosodimethylamine and N‐nitrosodiethylamine in mice and humansMolecular Carcinogenesis, 1993
- Cytochrome P450 2E1 and 2A6 enzymes as major catalysts for metabolic activation of N-nitrosodialkylamines and tobacco-related nitrosamines in human liver microsomesCarcinogenesis: Integrative Cancer Research, 1992
- Interindividual variability of coumarin 7-hydroxylation in healthy volunteersPharmacogenetics, 1992
- Human cytochrome P450IIA3: cDNA sequence role of the enzyme in the metabolic of promutagens comparison to nitrosamine activation by human cytochrome P450IIE1Carcinogenesis: Integrative Cancer Research, 1990